从新型冠状病毒肺炎防治策略探讨国医大师熊继柏用药特点  

Discussion on Medication Characteristics of TCM Master Xiong Jibai from the Prevention and Treatment Strategy of COVID-19

作　　者：朱成功 赵亭亭 谢雪姣 熊继柏(指导) ZHU Chenggong;ZHAO Tingting;XIE Xuejiao;XIONG Jibai(The Second Hospital of Hunan University of Chinese Medicine,Changsha 410005,China;Studio of Master of Chinese Medicine XIONG Jibai,Changsha 410007,China;The First Hospital of Hunan University of Chinese Medicine,Changsha 410007,China;College of Chinese Medicine,Hunan University of Chinese Medicine,Changsha 410208,China)

机构地区：[1]湖南中医药大学第二附属医院,湖南长沙410005 [2]国医大师熊继柏传承工作室,湖南长沙410007 [3]湖南中医药大学第一附属医院,湖南长沙410007 [4]湖南中医药大学中医学院,湖南长沙410208

出　　处：《中国中医药信息杂志》2021年第6期112-114,共3页Chinese Journal of Information on Traditional Chinese Medicine

基　　金：国家中医药管理局熊继柏国医大师工作室建设项目(2018年);湖南省教育科学“十二五”规划课题(XJK011BGD003)。

摘　　要：国医大师熊继柏教授从病名、病因、病性、病位四方面分析新型冠状病毒肺炎(以下简称"新冠肺炎"),并根据病机将其分为4期9型加以论治。这一新冠肺炎防治策略理法方药完备,学术特色鲜明,可从中窥见熊教授用药特点。本文初步总结了熊教授对新冠肺炎的防治策略及用药特点。This article introduced Professor Xiong Jibai’s comprehensive analysis on COVID-19 from four aspects: the name, causes, nature and location of the disease. Meanwhile he divided the syndrome differentiation and treatment of COVID-19 into four stages and nine types according to its pathogenesis. This prevention and treatment strategy of COVID-19 is complete in principles, methods, formulas and medicine, with distinct academic features, and medication characteristics of TCM master Xiong Jibai can be observed. This article preliminarily summarized the prevention and treatment strategy and medication characteristics of COVID-19 from Professor Xiong Jibai.

关 键 词：名医经验 熊继柏 新型冠状病毒肺炎 辨证论治 

分 类 号：R259.631[医药卫生—中西医结合]